T1	p 109 208	patients with primary Raynaud 's phenomenon in South Korea ; Korean Raynaud study ( KOARA study ) .
T2	p 356 385	primary Raynaud 's phenomenon
T3	p 396 403	Korea .
T4	p 1114 1131	Korean patients .
T5	p 1174 1182	patients
T6	i 44 54	nifedipine
T7	i 78 99	Ginkgo biloba extract
T8	i 256 266	nifedipine
T9	i 287 300	nifedipine SR
T10	i 317 338	Ginkgo biloba extract
T11	i 456 469	nifedipine SR
T12	i 495 516	Ginkgo biloba extract
T13	i 1023 1033	nifedipine
T14	i 1068 1082	biloba extract
T15	o 21 40	efficacy and safety
T16	o 233 241	efficacy
T17	o 246 252	safety
T18	o 277 284	release
T19	o 673 699	the RP attack rate between
T20	o 911 933	serious adverse events
T21	o 956 970	adverse events
T22	o 1023 1036	nifedipine SR